CCND1 and bladder transitional cell carcinoma: Moreover, Huang et al. reported that AP-2α suppressed hepatocellular carcinoma survival via the downregulation of, e.g., ERK, CCND1 or CD133 [57], the latter having a significant influence on BLCA viability [58].